Pharmaceutical Executive
Pharmaceutical Executive Podcast
The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry.
Episodes
Mentioned books
Oct 1, 2020 • 18min
Episode 66: New Approach to Antithrombotics
Dr. Neil Hayward, CEO and founder of eXlthera, is here to discuss his company, which is developing Factor XI inhibitor antithrombotics that are attacking blood clots from a new angle and are giving patients new hope.
Sep 17, 2020 • 15min
Episode 65: Creating a Path for Innovation
George Baxter, CEO of Edinburgh Innovations, is here to discuss the company's commercialization model, and how his group is bringing innovation to market in Scotland.
Sep 3, 2020 • 16min
Episode 64: The Complexities of Managing ADHD
Jack Khattar, president and CEO of Supernus Pharmaceuticals, talks about his experience bringing ADHD drugs to market in a challenging environment.
Aug 20, 2020 • 17min
Episode 63: Three Simple Principles to Improve Leadership
Eric Turbiville, author of the recently published book “The Perfect Leadership Triad: How Top Executives Maximize Productivity through People, Coaching, and Performance," a 25-year pharma veteran, credentialed executive coach, and director of mentoring for the Southwest region of the Healthcare Businesswomen’s Association says there are three leadership principles can help executives through tumultuous times, and is here to discuss how they can impact success.
Aug 6, 2020 • 19min
Episode 62: The Future of Pharma’s Supply Chain
Kurt Orlofski, CEO of Pharmaceutical Associates Inc., discusses what the pharmaceutical supply chain might look like post COVID-19, and how companies can prepare for that.
Jul 23, 2020 • 17min
Episode 61: Preparing for Virtual High-Stakes Meetings
Jim and Cindy DiBiasi, co-founders of 3D Communications, talk about how to prepare for virtual high-level meetings, such as important regulatory presentations and keynote addresses, in the wake of COVID-19.
Jul 9, 2020 • 14min
Episode 60: Leading With Compassion
Tim Walbert, CEO of Horizon Therapeutics, shares his unique perspective on managing the Chicago location of the company through COVID-19, in light of the fact that he himself is immunocompromised.
Jun 25, 2020 • 16min
Episode 59: Using Tau to Target Alzheimer’s
Janice Kranz, co-founder of Eikonizo Therapeutics, bring us up to date on how targeting tau to fight Alzheimer’s and other neurodegenerative diseases is making waves in the CNS space.
Jun 11, 2020 • 19min
Episode 58: Understanding FDA’s Gene Therapy Guidelines
Dr. Jonathan Gertler, CEO of Back Bay Life Science Advisors, and Dr. Stephan Gauldie, Managing Director of Back Bay, talk about the new guidelines set forth by FDA in regard to gene therapy, and what those new parameters mean for pharma and biotech.
May 28, 2020 • 18min
Episode 57: Planning for Pharma’s New Normal
Pratap Khedkar, managing principal of ZS Associates, talks about pharma’s scenario planning amid COVID-19 as it looks to settle into a new normal.
